Tevogen Bio Holdings (TVGN) Other Working Capital Changes (2022 - 2026)
Tevogen Bio Holdings (TVGN) reported Other Working Capital Changes of $341597.0 for Q1 2026, up 1268.14% on a YoY basis from $24968.0 in Q1 2025, and up 474.15% quarter-over-quarter from -$91299.0 in Q4 2025.
Tevogen Bio Holdings (TVGN) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Other Working Capital Changes for 5 years, with the latest figure at $341597.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 1268.14% year-over-year to $341597.0; the trailing twelve-month figure through Mar 2026 stood at $214791.0 (down 54.06% YoY), and the FY2025 full-year result was -$101838.0, down 119.93% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $341597.0, up from -$91299.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $513786.0 in Q4 2023, with the low at -$411025.0 in Q3 2024.
- Historically, Other Working Capital Changes has averaged $36574.5 across 5 years, with a median of -$50219.0 in 2022.
- Annual changes were most pronounced in 2025 — Other Working Capital Changes plunged 165.33% — and 2026, when it soared 1268.14%.
- Tevogen Bio Holdings' Other Working Capital Changes stood at -$130255.0 in 2022, then jumped by 494.45% to $513786.0 in 2023, then slipped by 13.86% to $442565.0 in 2024, then slumped by 120.63% to -$91299.0 in 2025, then surged by 474.15% to $341597.0 in 2026.
- The last three Other Working Capital Changes figures came in at $341597.0 (Q1 2026), -$91299.0 (Q4 2025), and $233005.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Tevogen Bio Holdings | 173.69 Mn | 173.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 341,597.00 |
| Mar 31, 2026 | 341,597.00 |
| Dec 31, 2025 | -91,299.00 |
| Dec 31, 2025 | -91,299.00 |
| Sep 30, 2025 | 233,005.00 |
| Sep 30, 2025 | 233,005.00 |
| Jun 30, 2025 | -268,512.00 |
| Jun 30, 2025 | -268,512.00 |
| Mar 31, 2025 | 24,968.00 |
| Mar 31, 2025 | 24,968.00 |
| Dec 31, 2024 | 442,565.00 |
| Dec 31, 2024 | 442,565.00 |
| Sep 30, 2024 | -411,025.00 |
| Sep 30, 2024 | -411,025.00 |
| Jun 30, 2024 | 411,025.00 |
| Jun 30, 2024 | 411,025.00 |
| Mar 31, 2024 | 68,446.00 |
| Mar 31, 2024 | 68,446.00 |
| Dec 31, 2023 | 513,786.00 |
| Dec 31, 2023 | 513,786.00 |